Added to YB: 2025-01-08
Pitch date: 2025-01-02
TMO [bullish]
Thermo Fisher Scientific Inc.
+9.45%
current return
Author Info
No bio for this author
Company Info
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
Market Cap
$215.6B
Pitch Price
$522.87
Price Target
N/A
Dividend
0.30%
EV/EBITDA
21.88
P/E
33.14
EV/Sales
5.67
Sector
Life Sciences Tools and Services
Category
value
Thermo Fisher Scientific Inc (NYSE:TMO, ETR:TN8)
TMO: Life sciences leader w/ diverse exposure & secular tailwinds. Indispensable in modern medicine dev. Strong growth opps, disciplined M&A. Current valuation below 10-yr avg P/E, attractive entry for long-term investors. Reliable earnings, dominant market position in diagnostics ecosystem.
Read full article (1 min)